Semaglutide
A synthetic analog of human Glucagon-Like Peptide-1 (GLP-1)
A revolutionary peptide for significant weight loss and blood sugar control.
Semaglutide is a GLP-1 receptor agonist, a class of peptides originally developed for managing Type 2 diabetes. It gained widespread recognition for its profound effects on weight loss, leading to its approval for chronic weight management under brand names like Wegovy and Ozempic. Its ability to reduce appetite and improve metabolic function has made it one of the most significant advancements in obesity treatment.
Key Benefits
Mechanism of Action
Semaglutide mimics the action of the endogenous hormone GLP-1, binding to and activating GLP-1 receptors. This activation increases insulin secretion in response to glucose, suppresses glucagon release, and significantly slows gastric emptying. Crucially, it also acts on appetite centers in the brain, particularly the hypothalamus, to reduce hunger and increase feelings of fullness (satiety).
Dosing Guidelines
Typical Dose
0.25 mg - 2.4 mg
Frequency
1x weekly
Duration
6+ months
Note: Administered via subcutaneous injection. Dosing must be titrated (started low and increased slowly over months) to minimize gastrointestinal side effects. For example: start at 0.25 mg/week for 4 weeks, then increase to 0.5 mg/week, and so on.
Research & Studies
An in-depth look at Semaglutide's mechanism, clinical trial data, dosing protocols, and side effect management for research purposes.
Read Full ResearchThis landmark clinical trial published in the NEJM demonstrated an average weight loss of ~15% in non-diabetic adults with obesity.
Read Full ResearchThis study showed that Semaglutide significantly reduced the risk of major adverse cardiovascular events in patients with type 2 diabetes.
Read Full ResearchA comparative overview of the different mechanisms and reported efficacies between single-agonist (Semaglutide) and dual-agonist (Tirzepatide) peptides.
Read Full ResearchPotential Side Effects
Reported side effects may include:
- • Nausea (most common, especially during dose titration)
- • Vomiting, diarrhea, and/or constipation
- • Abdominal pain and bloating
- • Fatigue, particularly during initial phases
- • Injection site reactions (redness, itching)
- • Rare but serious risks include pancreatitis and a boxed warning for thyroid C-cell tumors (based on rodent studies)
This information is for research purposes only. Always consult with a healthcare professional.
Popular Stacking Options
Semaglutide + CJC-1295 / Ipamorelin
To help preserve lean muscle mass during significant weight loss, as rapid fat loss can sometimes be accompanied by muscle catabolism.
Shop this stackSemaglutide + MOTS-c
To enhance mitochondrial function and cellular energy production, potentially improving metabolic efficiency and combating fatigue during a caloric deficit.
Shop this stackSemaglutide + BPC-157
To potentially mitigate gastrointestinal side effects like inflammation or discomfort, given BPC-157's gut-healing properties.
Shop this stackFrequently Asked Questions
How quickly does Semaglutide work for weight loss?
While appetite suppression can be noticed within the first few weeks, significant weight loss is a gradual process. Most clinical trials measure results over 6 to 12 months, with steady loss occurring as long as the peptide is used alongside diet and lifestyle changes.
What is the most common side effect and how is it managed?
Nausea is the most reported side effect. It is best managed by starting with a very low dose (e.g., 0.25 mg/week) and titrating up slowly every 4 weeks. Eating smaller, more frequent meals and avoiding high-fat foods can also help.
Will I regain the weight if I stop taking Semaglutide?
Semaglutide is a tool for weight management, not a permanent cure. Studies show that many individuals regain a significant portion of the lost weight after discontinuing the peptide if they do not maintain the diet and exercise habits established during treatment.
Do I still need to diet and exercise while using Semaglutide?
Yes. Semaglutide is most effective when used as an adjunct to a reduced-calorie diet and increased physical activity. It works by making it easier to adhere to these lifestyle changes through appetite control, but it does not replace them.
What's the difference between Semaglutide and Tirzepatide?
Semaglutide is a single-agonist peptide that only targets the GLP-1 receptor. Tirzepatide is a dual-agonist that targets both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, which has been shown in some studies to lead to even greater weight loss and glycemic control.
Ready to Purchase Semaglutide?
Get pharmaceutical-grade Semaglutide from Peptide Palace with 99%+ purity, third-party lab testing, and same-day dispatch.
Buy Semaglutide Now